Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DateTimeSourceHeadlineSymbolCompany
05/30/20243:01PMGlobeNewswire Inc.Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
05/07/20243:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
05/07/20243:05PMGlobeNewswire Inc.Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
05/01/20243:05PMGlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
04/24/20249:00AMGlobeNewswire Inc.Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
04/15/20248:00AMGlobeNewswire Inc.Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)NASDAQ:CRBUCaribou Biosciences Inc
04/04/20243:00PMGlobeNewswire Inc.Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusNASDAQ:CRBUCaribou Biosciences Inc
03/11/20244:08PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRBUCaribou Biosciences Inc
03/11/20243:25PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRBUCaribou Biosciences Inc
03/11/20243:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
03/11/20243:05PMGlobeNewswire Inc.Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
03/05/20243:30PMGlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20244:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/22/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
02/15/20243:05PMGlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
02/08/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
01/10/20243:18PMEdgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
01/09/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
01/09/20243:07PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
01/08/20243:18PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBUCaribou Biosciences Inc
01/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
01/07/202410:00AMGlobeNewswire Inc.Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024NASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU